The nasal carriage of *S. aureus*, including oxacillin-resistant *S. aureus* (ORSA), is well known to be a significant risk factor for subsequent infection ([@B03]), mainly in primary bacteremia ([@B19]) and surgical site infection after major heart surgery ([@B10]), as well as ventilator-associated pneumonia (VAP) ([@B03]). However, some studies have shown that the throat is also an important site of staphylococcal carriage ([@B11]; [@B15]; [@B09]), and oropharyngeal colonization plays a central role in the pathogenesis of VAP ([@B02]).

This study evaluated the relationship between previous colonization of the oropharynx and development of VAP by the analysis of genomic DNA-fingerprint patterns by pulsed-field gel electrophoresis (PFGE) of both ORSA and OSSA isolates from hospitalized patients in clinical-surgical intensive care unit (ICU) at Uberlândia Federal University Hospital Clinic (UFU-HC). UFU-HC is a teaching hospital with 500 beds and a clinical-surgical ICU for adults with 15 beds.

We conducted a longitudinal, prospective study for searching cases of oropharygeal colonization and VAP by *S. aureus* from May 2009 to August 2010. All patients admitted to the ICU requiring tracheal intubation and mechanical ventilation were eligible for inclusion in the study. The cultures of the oropharyngeal secretions were taken at baseline \< 24 h in the ICU) and every two days until the confirmation of colonization or discharge. The clinical specimen from the oropharynx was collected by swabbing the posterior pharyngeal wall. VAP criteria were: clinical, radiological and positive quantitative culture of the endotracheal aspirate (count ≥ 10^6^ cfu/mL) ([@B13]). Only the first episode of VAP was considered for each patient. The Ethics Committee for Human Research of the Uberlândia Federal University approved this study (protocol number 364/08).

Oropharynx and endotracheal aspirate samples were cultivated in salty mannitol agar (Biobras, Belo Horizonte, MG, Brazil) by qualitative and quantitative techniques, respectively. *S. aureus* isolates were identified by mannitol fermentation, Gram stain, catalase, tube coagulase and clumping tests. Resistance to oxacillin was detected by means of a screening test in salty mannitol agar (Biobras) supplemented with 6 μg/mL of oxacillin and 4.5% of NaCl ([@B04]), and confirmed by polymerase chain reaction (PCR) test, which was used to detect the presence of *mec*A gene ([@B14]).

Isolates from both oropharynx and tracheal aspirate of patients who developed VAP were typed using PFGE, according to [@B08]. Dendrograms were generated by using the software Bionumerics version 5.01 (Applied Maths). In addition, the band patterns were analyzed by visual comparison classified according to the criteria of [@B18].

In total, 617 patients were admitted to the adult ICU of the UFU-HC, and 346 (56.1%) of them were submitted to mechanical ventilation, of which 126 (36.4%) were colonized in the oropharynx with *S. aureus* (80/126; 63.5% were ORSA and 46/126; 36.5% were OSSA isolates).

For the total patients analyzed, VAP due to *S. aureus* was relatively low, corresponding to 11 cases (fourby ORSA and seven by OSSA), although high frequencies of colonization of the mucous membranes of the oropharynx by these microorganisms were found (ORSA 80/346; 23.1% and OSSA 46/346; 13.3%). Among the 126 colonized patients, a total of seven (5.5%) developed VAP: four (5.0%) of 80 caused by ORSA and three (6.5%) of 46 caused by ORSA.

PFGE analyses was carried out after *Sma*I-fragmentation of genomic DNA of 19 *S. aureus* isolated from 11 patients, corresponding to 11 samples of VAP and eight from colonized patients who developed VAP. In seven (63.6%) of 11 cases of VAP an identical strain was isolated from oropharynx and endotracheal aspirate samples. Only one PFGE profile of ORSA causing VAP was observed in four patients. These samples were genetically related to those of oropharyngeal colonization of these four different patients. Two PFGE patterns were identified among our OSSA isolates, with one pattern corresponding to the isolate 19, and one major pattern subdivided into two subtypes, including the most common ones \[isolates 01, 05, 06, 07, 08, 09, 10 and 11\] and a second corresponding to the isolate 16 ([Figure 1](#f01){ref-type="fig"}).
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Seven patients had VAP caused by OSSA, three were caused by isolates of same PFGE profile \[isolates 05, 07 and 09\]. These isolates were similar to those of oropharyngeal colonization of these patients \[isolates 06, 08 and 10\]. Three other patients had no oropharynx colonized but developed VAP by OSSA with two isolates belonging to the same clone, but different subtypes \[11 and 16\] and one isolate belonging to another clone \[sample 19\] ([Figure 1](#f01){ref-type="fig"}). Only one patient had discordant oropharyngeal \[isolate 02 -- ORSA\] and clinical isolates \[isolate 1 -- OSSA\] ([Figure 1](#f01){ref-type="fig"}).

The rate of colonization of the oropharyngeal mucosa by *S. aureus* in this study was high (36.4%), but similar to those reported in other studies ([@B06]; [@B11]). In the critically ill patients, the oral flora shifts dramatically to a predominance of enteric Gram-negative bacilli and *S. aureus*, upon to admission to the ICU ([@B16]; [@B07]). In the mechanically ventilated patient bacterial adherence is favored by reduced immunoglobulin A, augmented protease production, denuded mucous membrane, elevated airway pH, increased numbers of airway receptor for bacteria, due to acute illness, and antibiotic use ([@B16]; [@B07]).

The carriage of *S. aureus* in the upper respiratory tract, mainly ORSA, is well known to be a significant risk factor for subsequent infection ([@B03]), including VAP that usually follows microaspiration of oropharyngeal secretions colonized with potentially pathogenic microorganisms ([@B16]). In our study, among patients colonized with *S. aureus*, progression to VAP was 5.5%, as opposed to only 1.8% in non-colonized (p \> 0.05), whereas individuals colonized by ORSA and OSSA, 5.0% and 6.5% developed VAP respectively, instead of 0% and 1.3% (p = 0.003 / p = 0.05) those not colonized by these micro-organisms, respectively.

In opposition to that observed for OSSA, PFGE analyses revealed a genomic similarity for the ORSA isolates recovered from cases of VAP and oropharyngeal colonization. In Brazil, isolates of ORSA usually correspond to the "Brazillian epidemic clone" (BEC), which belongs to the type III SCCmec, and present disseminated intra-and inter-hospital in the country, so endemic in general hospitals ([@B05]; [@B17]; [@B12]). Nevertheless, we observed the presence of two OSSA clones, one represented by a single strain \[19\] and the other showing two subtypes with 100% and 91.5% similarity, respectively. Among patients who developed VAP by this phenotype, three were previously colonized with the same clone. Earlier, [@B01] reported that the oropharynx, alone or in association with the trachea was the initial site of colonization, with respectively, 13 and 14 microorganisms out of the 58 ones causing VAP.

In summary, despite the small number of isolates analyzed, the results of this study suggest an association between prior oropharyngeal colonization and VAP for *S. aureus*, with the same clones colonizing oropharynx and causing VAP.
